Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 151
interventional 136
Observational 13
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 60
Drug 59
Biological|placebo 5
Biological 3
Dietary Supplement|placebo 3
Drug|Other 2
Procedure 2
Biological|Drug|placebo 1
Biological|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 48
NA 35
Korea, Republic of 10
Japan 8
NA 3
China 3
United States|Canada 3
Austria 2
Germany 2
Taiwan 2
Thailand 2
Argentina|Australia|Korea, Republic of|Russian Federation 1
Australia 1
Belgium|Netherlands 1
Brazil 1
Canada 1
Canada|United States|Argentina|Chile|France|Italy|Peru 1
Denmark 1
Hong Kong 1
Italy 1
Norway 1
Philippines 1
Switzerland 1
United Kingdom 1
United States|Argentina|Chile|Finland|Italy|Mexico|Slovakia 1
United States|Australia|Canada|Estonia|Germany|Latvia|Lithuania|New Zealand|Russian Federation 1
United States|Canada|Estonia|Germany|Hungary|Russian Federation|Slovakia 1
United States|France 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 81
2 4
3 3
4 4
5 3
6 4
7 3
8 1
9 1
12 2
14 1
15 2
16 1
22 1
23 1
24 1
28 2
31 2
34 2
35 2
37 1
39 1
41 1
42 1
43 1
44 1
45 1
49 1
56 1
59 1
60 1
65 1
66 1
74 2

Phase

Phase Study_Count
Phase 3 74
Phase 4 32
Phase 1 10
Phase 2 10
N/A 5
Phase 1/Phase 2 4
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 20
2 62
3 22
4 7
5 1
6 2
7 1
NA 21

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 30 11.00 12.00 20.00 100 30.0000 30.0000
1st Qu. 36 22.00 33.00 72.75 100 106.0000 61.5000
Median 64 30.00 47.00 100.00 100 284.5000 235.0000
Mean 122 47.30 51.25 173.50 100 386.8108 283.4375
3rd Qu. 64 41.25 65.25 125.50 100 542.5000 364.2500
Max. 416 195.00 99.00 630.00 100 1992.0000 1260.0000

Trial Group Type

group_type Group_Count
Experimental 136
Placebo Comparator 70
Active Comparator 53
NA 21
Other 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 95
Crossover Assignment 24
Single Group Assignment 17

Primary Purpose

primary_purpose Study_Count
Treatment 123
NA 7
Prevention 3
Other 2
Basic Science 1

Observational Studies

Studies by Country

Country Study_Count
NA 9
United States 2
Italy 1
Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 13

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 60.000
Median 1003.000
Mean 2600.077
3rd Qu 3244.000
Max 10728.000

Observation Model

observational_model Study_Count
Cohort 6
Ecologic or Community 3
NA 2
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 9
Retrospective 3
Cross-Sectional 1

Registries

Studies by Country

Country Study_Count
Austria 1
United States 1

Sites per Study

Site_count Study_Count
1 1
46 1

Enrollment Metrics

Measure Registries
Min 32
1st Qu 230
Median 428
Mean 428
3rd Qu 626
Max 824

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
6 Months 2

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03317015 A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT03317015 Completed Sanofi 2017-07-10
NCT02709538 Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT02709538 Completed Glenmark Specialty S.A. 2017-07-31
NCT02686294 Repeated Dosing Clinical Trial of HL151 https://ClinicalTrials.gov/show/NCT02686294 Completed Hanlim Pharm. Co., Ltd. 2016-03-15
NCT02682745 Single Dosing Clinical Trial of HL151 https://ClinicalTrials.gov/show/NCT02682745 Completed Hanlim Pharm. Co., Ltd. 2016-02-12
NCT02532179 Subcutaneous Immunotherapy for Mouse in Adults https://ClinicalTrials.gov/show/NCT02532179 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-10-31
NCT02498509 Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 https://ClinicalTrials.gov/show/NCT02498509 Completed Chong Kun Dang Pharmaceutical 2016-03-31
NCT02443805 Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR https://ClinicalTrials.gov/show/NCT02443805 Completed Stallergenes Greer 2018-06-25
NCT02424539 A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR) https://ClinicalTrials.gov/show/NCT02424539 Completed GlaxoSmithKline 2017-10-25
NCT02397915 Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays https://ClinicalTrials.gov/show/NCT02397915 Completed GlaxoSmithKline 2015-06-08
NCT02339714 Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02339714 Completed China Academy of Chinese Medical Sciences 2016-05-31
NCT02182544 WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02182544 Completed Boehringer Ingelheim 2001-12-31
NCT02182518 Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02182518 Completed Boehringer Ingelheim 2001-07-31
NCT01287364 Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01287364 Completed Sunovion 2011-04-30
NCT01270958 A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01270958 Completed GlaxoSmithKline 2010-02-28
NCT01270256 NasoNeb Delivery of an Intranasal Steroid https://ClinicalTrials.gov/show/NCT01270256 Completed University of Chicago 2012-07-31
NCT03360071 A Novel Biologic Therapy for Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT03360071 Completed Johns Hopkins University 2018-06-30
NCT01982916 Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean https://ClinicalTrials.gov/show/NCT01982916 Completed Ahn-Gook Pharmaceuticals Co.,Ltd 2015-01-31
NCT01962467 A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine https://ClinicalTrials.gov/show/NCT01962467 Completed GlaxoSmithKline 2014-02-27
NCT01957202 A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) https://ClinicalTrials.gov/show/NCT01957202 Completed GlaxoSmithKline 2014-02-28
NCT01949051 A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01949051 Completed GlaxoSmithKline 2014-02-04
NCT01918033 A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) https://ClinicalTrials.gov/show/NCT01918033 Completed Merck Sharp & Dohme Corp. 2014-01-26
NCT01900054 A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01900054 Completed Mitsubishi Tanabe Pharma Corporation 2013-11-30
NCT01861522 The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01861522 Completed Mitsubishi Tanabe Pharma Corporation 2013-12-31
NCT01852812 Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) https://ClinicalTrials.gov/show/NCT01852812 Completed Merck Sharp & Dohme Corp. 2013-12-24
NCT01779895 Probiotic Administration and Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01779895 Completed Nestlé 2013-01-31
NCT01700192 Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) https://ClinicalTrials.gov/show/NCT01700192 Completed ALK-Abelló A/S 2015-04-30
NCT01697956 Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT01697956 Completed Teva Pharmaceutical Industries 2013-02-28
NCT01678807 Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) https://ClinicalTrials.gov/show/NCT01678807 Completed ALK-Abelló A/S 2013-05-31
NCT01654536 A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT01654536 Completed Sunovion 2013-07-31
NCT01644617 A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627) https://ClinicalTrials.gov/show/NCT01644617 Completed ALK-Abelló A/S 2013-08-31
NCT01640535 Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients https://ClinicalTrials.gov/show/NCT01640535 Completed Hanmi Pharmaceutical Company Limited 2013-02-28
NCT01630135 Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01630135 Completed GlaxoSmithKline 2012-08-31
NCT01622283 Pharmacokinetic Study of Levocetirizine Oral Solution https://ClinicalTrials.gov/show/NCT01622283 Completed GlaxoSmithKline 2012-06-10
NCT01622231 Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01622231 Completed GlaxoSmithKline 2012-11-30
NCT01539304 Clinical Trial to Evaluate the Safety and Efficacy of “CITUS Dry Syrup” in Children With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01539304 Completed SamA Pharmaceutical Co., Ltd 2011-08-31
NCT01470053 Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01470053 Completed Hanlim Pharm. Co., Ltd. 2011-12-31
NCT01451541 A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). https://ClinicalTrials.gov/show/NCT01451541 Completed Sunovion 2012-12-31
NCT01425632 A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01425632 Completed Mitsubishi Tanabe Pharma Corporation 2011-12-31
NCT01401465 Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray https://ClinicalTrials.gov/show/NCT01401465 Completed Sunovion 2011-11-30
NCT01380327 Biomarkers of Cockroach Sublingual Immunotherapy 2 https://ClinicalTrials.gov/show/NCT01380327 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2012-06-30
NCT01378429 Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01378429 Completed Sunovion 2011-11-30
NCT04388358 Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation https://ClinicalTrials.gov/show/NCT04388358 Recruiting Chang Gung Memorial Hospital 2020-07-31
NCT04332978 Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene https://ClinicalTrials.gov/show/NCT04332978 Completed Libbs Farmacêutica LTDA 2020-04-01
NCT04324918 Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT04324918 Completed Hanmi Pharmaceutical Company Limited 2019-06-24
NCT04024033 Effects of Pine Cone Extract on Serum IgE Levels in Perennial Rhinitis https://ClinicalTrials.gov/show/NCT04024033 Active, not recruiting University of South Florida 2020-01-31
NCT03655210 To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients https://ClinicalTrials.gov/show/NCT03655210 Completed Hanlim Pharm. Co., Ltd. 2017-02-20
NCT01244217 Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT01244217 Completed Sanofi 2011-07-31
NCT01231464 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01231464 Completed GlaxoSmithKline 2010-05-31
NCT01228630 Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis. https://ClinicalTrials.gov/show/NCT01228630 Completed Azidus Brasil 2012-04-30
NCT01221285 Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium https://ClinicalTrials.gov/show/NCT01221285 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-10-31
NCT01216384 Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers https://ClinicalTrials.gov/show/NCT01216384 Completed Boehringer Ingelheim 2010-12-31
NCT01165424 A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1) https://ClinicalTrials.gov/show/NCT01165424 Completed Merck Sharp & Dohme Corp. 2010-12-31
NCT01154153 Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01154153 Completed Sanofi 2010-10-31
NCT01135134 Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) https://ClinicalTrials.gov/show/NCT01135134 Completed Merck Sharp & Dohme Corp. 2010-10-31
NCT01134705 Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) https://ClinicalTrials.gov/show/NCT01134705 Completed Teva Pharmaceutical Industries 2010-10-31
NCT01133626 Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT01133626 Completed Teva Pharmaceutical Industries 2010-09-30
NCT01127620 Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension https://ClinicalTrials.gov/show/NCT01127620 Completed Faes Farma, S.A. 2006-03-31
NCT01116778 the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01116778 Completed GenMont Biotech Incorporation 2012-01-31
NCT01115595 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais https://ClinicalTrials.gov/show/NCT01115595 Completed Mahidol University 2013-10-31
NCT01067105 A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older https://ClinicalTrials.gov/show/NCT01067105 Completed Sunovion 2010-11-30
NCT01033825 Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis https://ClinicalTrials.gov/show/NCT01033825 Completed Sunovion 2010-05-31
NCT01018862 A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01018862 Completed Meda Pharmaceuticals 2011-04-30
NCT00988247 Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00988247 Completed Teva Pharmaceutical Industries 2011-02-28
NCT00974571 Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246) https://ClinicalTrials.gov/show/NCT00974571 Completed Merck Sharp & Dohme Corp. 2002-05-31
NCT00963573 Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) https://ClinicalTrials.gov/show/NCT00963573 Completed Merck Sharp & Dohme Corp. 2006-11-30
NCT00953147 A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older https://ClinicalTrials.gov/show/NCT00953147 Completed Sunovion 2010-01-31
NCT00894231 Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00894231 Completed AAADRS Clinical Research Center 2009-08-31
NCT00848965 A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber https://ClinicalTrials.gov/show/NCT00848965 Completed GlaxoSmithKline 2008-01-31
NCT00839189 Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults https://ClinicalTrials.gov/show/NCT00839189 Completed University of North Carolina, Chapel Hill 2006-06-30
NCT00829985 Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) https://ClinicalTrials.gov/show/NCT00829985 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-12-31
NCT00822406 Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00822406 Completed University of Sao Paulo NA
NCT01916226 A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01916226 Completed GlaxoSmithKline 2013-10-01
NCT00806754 Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) https://ClinicalTrials.gov/show/NCT00806754 Completed AstraZeneca 2007-05-31
NCT00794846 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180) https://ClinicalTrials.gov/show/NCT00794846 Completed Merck Sharp & Dohme Corp. 2003-05-31
NCT00794599 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) https://ClinicalTrials.gov/show/NCT00794599 Completed Merck Sharp & Dohme Corp. 2003-08-31
NCT00794495 Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) https://ClinicalTrials.gov/show/NCT00794495 Completed Merck Sharp & Dohme Corp. 2003-07-31
NCT00789555 Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00789555 Completed Alcon Research 2011-01-31
NCT00783224 A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) https://ClinicalTrials.gov/show/NCT00783224 Completed Merck Sharp & Dohme Corp. 2005-11-30
NCT00779740 Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419) https://ClinicalTrials.gov/show/NCT00779740 Completed Merck Sharp & Dohme Corp. 2005-04-01
NCT00779545 A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) https://ClinicalTrials.gov/show/NCT00779545 Completed Merck Sharp & Dohme Corp. 2004-08-06
NCT00771160 MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED) https://ClinicalTrials.gov/show/NCT00771160 Completed Merck Sharp & Dohme Corp. 2005-02-28
NCT00741897 Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00741897 Completed Sanofi 2003-12-31
NCT00732368 A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) https://ClinicalTrials.gov/show/NCT00732368 Completed Merck Sharp & Dohme Corp. 2006-01-01
NCT00730912 Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539) https://ClinicalTrials.gov/show/NCT00730912 Completed Merck Sharp & Dohme Corp. 2008-12-31
NCT00730756 A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis https://ClinicalTrials.gov/show/NCT00730756 Completed GlaxoSmithKline 2009-02-28
NCT00720382 A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00720382 Completed Meda Pharmaceuticals 2008-06-30
NCT00712920 A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies https://ClinicalTrials.gov/show/NCT00712920 Completed Meda Pharmaceuticals 2008-05-31
NCT00682643 A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00682643 Completed GlaxoSmithKline 2011-02-28
NCT00659750 To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) https://ClinicalTrials.gov/show/NCT00659750 Completed AstraZeneca 2004-05-31
NCT00659048 Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) https://ClinicalTrials.gov/show/NCT00659048 Completed AstraZeneca 2005-04-30
NCT00658918 To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) https://ClinicalTrials.gov/show/NCT00658918 Completed AstraZeneca 2005-04-30
NCT00641212 Children, Perennial Allergic Rhinitis (PAR), l-t Growth https://ClinicalTrials.gov/show/NCT00641212 Completed AstraZeneca 2003-04-30
NCT00639587 Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00639587 Completed UCB Pharma 2003-03-31
NCT00638755 The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00638755 Completed Capnia, Inc. 2008-05-31
NCT00609674 A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00609674 Completed GlaxoSmithKline 2008-06-30
NCT00590772 The Role of Montelukast in Rhinitis and Sleep https://ClinicalTrials.gov/show/NCT00590772 Completed Penn State University 2009-01-31
NCT00578331 Safety Study of Olopatadine Nasal Spray https://ClinicalTrials.gov/show/NCT00578331 Completed Alcon Research 2008-01-31
NCT00570492 Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. https://ClinicalTrials.gov/show/NCT00570492 Completed GlaxoSmithKline 2011-03-01
NCT00539006 Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS https://ClinicalTrials.gov/show/NCT00539006 Completed GlaxoSmithKline 2007-11-30
NCT00524836 Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00524836 Completed UCB Pharma 2004-02-29
NCT00521131 Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites https://ClinicalTrials.gov/show/NCT00521131 Completed UCB Pharma 2003-05-31
NCT00519636 Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS https://ClinicalTrials.gov/show/NCT00519636 Completed GlaxoSmithKline 2007-11-30
NCT00490204 Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00490204 Completed GlaxoSmithKline 2007-10-03
NCT00456755 Herbal Treatment for Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00456755 Completed Chinese University of Hong Kong 2006-04-30
NCT00449072 Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT00449072 Completed Sanofi 2011-10-31
NCT00439712 Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00439712 Completed Institut für Atemwegsforschung GmbH 2007-05-31
NCT00406783 Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) https://ClinicalTrials.gov/show/NCT00406783 Completed Merck Sharp & Dohme Corp. 2007-11-30
NCT00404586 Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber https://ClinicalTrials.gov/show/NCT00404586 Completed GlaxoSmithKline 2007-01-16
NCT00398476 Fluticasone Nasal Spray Patient Preference Study https://ClinicalTrials.gov/show/NCT00398476 Completed GlaxoSmithKline 2006-12-04
NCT00359216 The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) https://ClinicalTrials.gov/show/NCT00359216 Completed Merck Sharp & Dohme Corp. 2008-01-31
NCT00358475 Study Of Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00358475 Completed GlaxoSmithKline 2005-10-01
NCT00346775 Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) https://ClinicalTrials.gov/show/NCT00346775 Completed GlaxoSmithKline 2006-06-29
NCT00289198 Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) https://ClinicalTrials.gov/show/NCT00289198 Completed GlaxoSmithKline 2006-07-01
NCT00261287 Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) https://ClinicalTrials.gov/show/NCT00261287 Completed AstraZeneca 2006-06-30
NCT00257595 Perennial Allergic Rhinitis In Pediatric Subjects https://ClinicalTrials.gov/show/NCT00257595 Completed GlaxoSmithKline NA
NCT00253058 Study Of Perennial Allergic Rhinitis In Pediatrics https://ClinicalTrials.gov/show/NCT00253058 Completed GlaxoSmithKline NA
NCT00232518 Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis https://ClinicalTrials.gov/show/NCT00232518 Completed University of Nottingham NA
NCT00224523 Long Term Safety Of GW685698X Via Nasal Biopsy https://ClinicalTrials.gov/show/NCT00224523 Completed GlaxoSmithKline 2007-02-28
NCT00210015 A Study in Subjects With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00210015 Completed Merck Sharp & Dohme Corp. 2003-04-30
NCT00163514 Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) https://ClinicalTrials.gov/show/NCT00163514 Completed AstraZeneca 2005-07-31
NCT00163501 Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) https://ClinicalTrials.gov/show/NCT00163501 Completed AstraZeneca 2005-04-30
NCT00163488 Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) https://ClinicalTrials.gov/show/NCT00163488 Completed AstraZeneca 2005-08-31
NCT00160680 ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) https://ClinicalTrials.gov/show/NCT00160680 Completed UCB Pharma 2006-06-01
NCT00160589 LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) https://ClinicalTrials.gov/show/NCT00160589 Completed UCB Pharma 2005-09-30
NCT00159523 Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic https://ClinicalTrials.gov/show/NCT00159523 Completed Norwegian University of Science and Technology 2007-09-30
NCT00132925 An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00132925 Completed Sanofi NA
NCT00116883 A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics https://ClinicalTrials.gov/show/NCT00116883 Completed GlaxoSmithKline 2005-07-31
NCT00116818 A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults https://ClinicalTrials.gov/show/NCT00116818 Completed GlaxoSmithKline 2005-05-31
NCT00109486 Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray https://ClinicalTrials.gov/show/NCT00109486 Completed GlaxoSmithKline 2005-11-30
NCT00108914 Perennial Allergic Rhinitis Study In Pediatric Subjects https://ClinicalTrials.gov/show/NCT00108914 Completed GlaxoSmithKline 2005-11-30
NCT00107757 Seasonal Allergic Rhinitis In Pediatric Subjects https://ClinicalTrials.gov/show/NCT00107757 Completed GlaxoSmithKline NA
NCT00103454 A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). https://ClinicalTrials.gov/show/NCT00103454 Completed GlaxoSmithKline 2005-05-31
NCT00092118 The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) https://ClinicalTrials.gov/show/NCT00092118 Completed Merck Sharp & Dohme Corp. 2004-05-31
NCT00092105 Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) https://ClinicalTrials.gov/show/NCT00092105 Completed Merck Sharp & Dohme Corp. 2003-01-01
NCT00041821 Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity https://ClinicalTrials.gov/show/NCT00041821 Completed National Institute of Environmental Health Sciences (NIEHS) NA
NCT00434421 Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma https://ClinicalTrials.gov/show/NCT00434421 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-08-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03286049 Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age https://ClinicalTrials.gov/show/NCT03286049 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2018-07-31
NCT02238236 Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus https://ClinicalTrials.gov/show/NCT02238236 Completed Boehringer Ingelheim 2008-04-30
NCT02238223 Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet https://ClinicalTrials.gov/show/NCT02238223 Completed Boehringer Ingelheim 2006-05-31
NCT01699659 The Efficacy & Safety of the UAS Immunotherapy Protocol https://ClinicalTrials.gov/show/NCT01699659 Completed United Allergy Services 2012-09-30
NCT01549340 Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) https://ClinicalTrials.gov/show/NCT01549340 Completed ALK-Abelló A/S 2012-05-31
NCT01445262 Drug Use Investigation for XYZAL® https://ClinicalTrials.gov/show/NCT01445262 Completed GlaxoSmithKline 2013-12-31
NCT01199757 A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures https://ClinicalTrials.gov/show/NCT01199757 Completed GlaxoSmithKline 2009-08-01
NCT01077609 Flixonase Safety in Patients With Allergic Rhinitis (AR) https://ClinicalTrials.gov/show/NCT01077609 Completed GlaxoSmithKline 2010-04-30
NCT01001130 Regulatory AVAMYS Nasal Spray PMS https://ClinicalTrials.gov/show/NCT01001130 Completed GlaxoSmithKline 2014-05-31
NCT00762983 Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) https://ClinicalTrials.gov/show/NCT00762983 Completed Merck Sharp & Dohme Corp. 2009-02-28
NCT00761527 Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) https://ClinicalTrials.gov/show/NCT00761527 Completed Merck Sharp & Dohme Corp. 2010-05-31
NCT00704769 Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) https://ClinicalTrials.gov/show/NCT00704769 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT00405899 Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections https://ClinicalTrials.gov/show/NCT00405899 Completed West Penn Allegheny Health System NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03127436 Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe https://ClinicalTrials.gov/show/NCT03127436 Completed University Hospital of Cologne 2019-02-14
NCT01632540 Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01632540 Completed Teva Pharmaceutical Industries 2013-12-31